Stock Market Reviews

ANL (Adlai Nortye Ltd.) News

Get the latest news, insights, and market updates on ANL (Adlai Nortye Ltd.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China
  SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it has entered into an exclusive licensing agreement with ASK Pharm for its proprietary pan-RAS (ON) inhibitor AN9025. Under the terms of the agreement, ASK Pharm will obtain exclusive rights to develop, manufacture, and co
  Dec 29, 2025 - $ANL
• Adlai Nortye to Participate in Upcoming Investor Conferences
  SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that members of its management team are scheduled to participate in the following investor conferences: The 8th Annual Evercore Healthcare ConferenceFormat: Fireside ChatHost: Jonathan MillerDate and Time: Tuesday, December 2, 2
  Nov 21, 2025 - $ANL
• Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
  SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it will deliver an oral presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held from October 22-26, 2025, in Boston, MA. Key highlights of the presentation include: AN4
  Oct 22, 2025 - $ANL
• Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
  SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it will deliver an oral presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held from October 22-26, 2025, in Boston, MA. Presentation details are as follows: Abstract t
  Oct 14, 2025 - $ANL
• Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025
  SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, April 10, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced the presentation at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago. Adlai Nortye has two abstracts scheduled for presentations at AACR. "We are pleased to present
  Apr 10, 2025 - $ANL
• Adlai Nortye And 2 Other Penny Stocks On US Exchanges To Watch
  The U.S. stock market has recently experienced volatility, driven by trade policy uncertainties and fluctuating corporate results, with tariffs on Mexico being delayed as a temporary relief. Amidst this backdrop, penny stocks continue to attract attention for their potential to offer growth opportunities in smaller or emerging companies. While the term "penny stocks" may seem outdated, these investments can still provide value when backed by strong financial health and a clear growth trajectory.
  Feb 3, 2025 - $ANL
• 3 US Penny Stocks With Market Caps Over $80M To Watch
  As the U.S. stock market concludes a strong year on a weak note, with major indices like the Dow experiencing significant monthly losses, investors are reflecting on opportunities within various sectors. Penny stocks, often associated with smaller or newer companies, remain an intriguing area for those seeking potential growth despite their somewhat outdated label. By focusing on companies that exhibit solid financial health and promising prospects, investors can uncover potential value in...
  Jan 1, 2025 - $ANL